Teoxane to Launch First APAC Regional Academy in Bangkok
New hub strengthens Teoxane's commitment to scientific education and clinical partnerships across Asia-Pacific GENEVA, Jan. 14, 2026 /PRNewswire/ -- Teoxane opens its first APAC Regional Academy in Bangkok, Thailand this January, expanding its global medical-education network. Located on Level 12 of One Bangkok Tower 4, the hub offers a modern environment designed to...
DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS
SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer diagnostics company Noul to certify their malaria diagnosis, blood cell morphology and cervical cancer testing solutions, under the European Union's In Vitro Diagnostic Medical Device Regulation (IVDR). ...
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Rakuten Medical, Inc. and LOTTE Biologics today announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to strengthen Rakuten Medical's production capabilities for its innovative oncology therapy, Alluminox® platform-based photoimmunotherapy. Signing...
Firstsource Acquires TeleMedik To Bolster Digital Offerings and Expand Presence in U.S. Healthcare Payer and Provider Markets
MUMBAI, India and DALLAS, Jan. 14, 2026 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), a leading global provider of business management services and an RP-Sanjiv Goenka Group company, today announced the acquisition of TeleMedik, a Puerto Rico based pioneer in the development and implementation of technological solutions. The acquisition significantly strengthens Firstsource's end-to-end clinical...
ArisGlobal Accelerates Growth and AI Adoption Following Strong 2025 Performance
More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum BOSTON, Jan. 14, 2026 /PRNewswire/ -- ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere® , today announced strong results for 2025, marked by sustained customer...
Picarro Sets New Standard in Fenceline Monitoring for Hazardous Air Pollutants
Comprehensive Solution Delivers Real-Time, Defensible Measurements, Transforming Fenceline Monitoring into a Proactive Compliance and Risk Management Tool SANTA CLARA, Calif., Jan. 13, 2026 /PRNewswire/ -- Picarro, Inc., a global leader in emissions monitoring, analytics, and services, today announced a breakthrough in air-quality compliance with the release of its Fenceline Solution. Picarro's...
Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS
NANTONG, China, Jan. 13, 2026 /PRNewswire/ -- Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral sclerosis (ALS). The initial dosing occurred at Second Affiliated Hospital, Zhejiang University School of Medicine, under the leadership of Dr. Zhi-Ying Wu, head...
Leo International Group Relocates Global Headquarters to Singapore Ahead of Its Centennial
Embodying a New Model of Inter-generational Enterprise Anchored in Healthcare, Finance and Education SINGAPORE, Jan. 13, 2026 /PRNewswire/ -- As Leo International Group approaches its centennial year in 2026, the Group is not merely commemorating a hundred years of legacy and commercial success. With the formal relocation of its global headquarters to Singapore...
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2 CAR-T therapy, in patients with advanced gastric cancer and gastroesophageal junction cancer (GC/GEJ). The data were presented as a poster (Abstract No. 398) at the 2026...
ER-VIPE Simulation Game Builds Medical Students’ Soft Skillsfor Real-World Emergency Care
BANGKOK, Jan. 13, 2026 /PRNewswire/ -- Chulalongkorn University's Faculty of Medicine has developed ER-VIPE, a virtual emergency-room simulation platform designed to strengthen teamwork, communication, and critical-thinking skills among future healthcare professionals. Supported by the university's Second Century Fund (C2F) since 2020, the program enables students from five disciplines—medicine, nursing, pharmacy, radiologic technology, and medical technology—to train together through high-pressure emergency...
